MEI Pharma (MEIP) Misses Q2 EPS by 166c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
Tweet
Share
E-mailGet Alerts MEIP Hot Sheet
Join SI Premium – FREE
MEI Pharma (NASDAQ: MEIP) reported Q2 EPS of ($1.66).
For earnings history and earnings-related data on MEI Pharma (MEIP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lamar Advertising (LAMR) Misses Q3 EPS by 6c ; Offers Guidance
- Gibraltar Industries (ROCK) Misses Q3 EPS by 23c; offers guidance
- Prestige Brands (PBH) Tops Q2 EPS by 5c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
